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Abstract
Background: Surveys indicate quite high prevalence of cancer worry in the general population, but little is known
about what it is about cancer that worries people. A better understanding of the origins of cancer worry may help
elucidate previously found inconsistencies in its behavioural effect on cancer prevention, screening uptake, and
help-seeking for symptoms. In this study, we explore the prevalence and population distribution of general cancer
worry and worries about specific aspects of cancer previously identified.
Methods: A population-based survey of 2048 English adults (18–70 years, April–May 2016), using face-to-face interviews
to assess demographic characteristics, general cancer worry and twelve sources of cancer worry (adapted from an
existing scale), including the emotional, physical, and social consequences of a diagnosis.
Results: In general, a third of respondents (37%) never worried about cancer, 57% worried occasionally/sometimes,
and 6% often/very often. In terms of specific worries, two thirds would be ‘quite a bit’ or ‘extremely’ worried about the
threat to life and emotional upset a diagnosis would cause. Half would worry about surgery, radiotherapy, chemotherapy,
and loss of control over life. Worries about the social consequences were less commonly anticipated: just under half
would worry about financial problems or their social roles, and a quarter would be worried about effects on identity,
important relationships, gender role, and sexuality. Women and younger people reported more frequent worry about
getting cancer, and would be more worried about the emotional, physical, and social consequences of a cancer diagnosis
(p< .001). Those from ethnic minority backgrounds reported less frequent worry about getting cancer than their white
counterparts, but would be equally worried about the emotional and physical impact of a cancer diagnosis, and worried
more about the social consequences of a cancer diagnosis (p< .05).
Conclusions: The majority of English adults worry at least occasionally about getting cancer, and would be most worried
about the emotional and physical impact of a cancer diagnosis. Distinguishing between the various worries that cancer
can evoke may help inform efforts to allay undue worries in those who are deterred by them from engaging with cancer
prevention and early detection.
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Background
Population surveys in the UK and US show that 25–50%
of people worry about getting cancer), with 5 to 10% being
extremely worried [1–3]. Cancer worry, defined as a nega-
tive emotional reaction to the threat of cancer [4], is often
operationalised as a unidimensional construct. Studies
usually measure its frequency [5–7], intensity [3, 5, 8], the
physical experiences associated with this negative
emotional reaction, such as fear or anxiety [3, 9], or a
combination [5]. However, little is known about whether
there could be different aspects of cancer that evoke
different worries in people in the general population.
Cancer worry in the general population has been
shown to affect uptake of cancer screening [4, 10], help-
seeking for possible cancer symptoms [11, 12], and
adoption of cancer-preventive health behaviours [1].
However, some of these studies have found that worry is
a motivator and others that it is a deterrent. Some
authors have suggested that it may be necessary to iden-
tify the specific origins of cancer-related worry to make
sense of the inconsistencies observed in cancer worry’s
behavioural effects [4, 13].
The idea that the behavioural effect of worry is
dependent on its source, is consistent with health behav-
iour theories that assign a central role to efficacy beliefs in
dealing with a threat, such as Witte’s Extended Parallel
Process Model (EPPM) [14] or Rogers’ Protection Motiv-
ation Theory [15]. For example, according to Witte’s
EPPM, the response to a perceived threat is dependent on
the outcome of an efficacy appraisal, including beliefs
about self- and response-efficacy. If efficacy is high, the be-
havioural response will aim to avert the danger associated
with the threat. If efficacy is low, the behavioural response
will aim to decrease the fear associated with the threat, ra-
ther than the threat itself. Since efficacy beliefs are guided
by the nature of the threat, it follows that the behavioural
response may differ. An example of this is a US-based
study of prostate cancer screening which found that worry
about prostate cancer was associated with more frequent
screening to obtain reassurance, while fear of screening led
to less frequent screening [16]. This study suggests that
deterring effects of screening fears could be addressed by
increasing efficacy beliefs about screening (e.g. self-
efficacy). If, on the other hand, interventions were devel-
oped to reduce worry about prostate cancer, for example,
by developing strategies to cope with prostate cancer
worry, then this could be expected to result in lower
screening uptake. Although this study measured fear of
the screening procedure itself rather than fear of screening
outcomes, it highlights the need for a more precise and
comprehensive definition and operationalisation of ‘cancer
worry’ in the general population. Because 1 in 2 people in
the UK born after 1960 are expected to develop cancer
within their lifetime [17], it is important to understand
how cancer-related worries in those without a cancer diag-
nosis in the general population may affect behaviours such
as screening uptake and help-seeking for symptoms to
inform efforts to increase informed participation in cancer
prevention and early detection. However, as the above
study shows [16], interventions to increase efficacy in deal-
ing with the threat of cancer would likely depend on the
nature of the worry cancer evokes.
In contrast to population-based studies about cancer
screening and public health, studies in cancer patients
already tend to operationalise fear of cancer recurrence1
as a multidimensional construct, including fears about
further treatment, loss of autonomy, and the effects of a
recurrence on social activities, work, the partner, or the
family [18–20]. Studies in those seeking help for possible
cancer symptoms also suggest multidimensionality,
including fears about the physical and financial conse-
quences of cancer treatment, suffering, body disfigure-
ment, leaving others behind, and death [11, 12, 21, 22].
Thus, in these subpopulations, cancer appears to evoke
a wide range of fears.
Evidence that cancer worry may also be multidi-
mensional in the general population comes from a
recent systematic review of 102 qualitative studies
carried out in the context of cancer screening [23]. In
those eligible for screening, cancer worry manifested
itself as a general worry about cancer, or as specific
worries, such as about the emotional and physical
consequences of a diagnosis (for example, chemother-
apy and surgery), the social consequences of a diag-
nosis, or dying from cancer. Thus, this review
suggests that cancer worry in the general population
may have various specific origins. However, the quali-
tative nature of this review prevents any conclusions
about the prevalence, population distribution, or
behavioural effects of these different types of worry.
The present study aims to provide a starting point to
exploring the usefulness of distinguishing between
different origins of cancer worry in the general popu-
lation who have not been diagnosed with cancer, by
examining their prevalence and whether responses
vary by demographic group. We chose to focus on
twelve specific cancer worries that were commonly
reported in the aforementioned qualitative review of
the literature about cancer screening in the general
population, and may therefore be hypothesised to be
main cancer worries among the general population
[23]. We also compare anticipated worries about
these twelve aspects of a cancer diagnosis with a
commonly-used measure of general cancer worry [24].
Previous studies have shown that general cancer
worry is higher in women, in those who are younger,
and in those from more deprived or ethnic minority
backgrounds [16, 25–27].
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Methods
Design and procedure
Data were collected as part of the third wave of the Atti-
tudes, Behaviour, and Cancer UK Survey (ABACUS),
using home-based face-to-face computer-assisted inter-
views conducted by market research agency TNS
Research International as part of their weekly omnibus
survey. This survey uses random location sampling of
sample points defined by the 2011 Census small area
statistics and the Postcode Address File. At each loca-
tion, quotas are set for age, gender, working status, and
children in the household.
Participants
Interviews with 2048 adults aged 18–70 years were con-
ducted in the respondents’ homes in England in April
and May 2016. This age range was chosen to reflect the
adult population in England, but since the survey was
part of a module about attitudes towards cancer and
cancer screening, the upper age limit was set at 70 years
because this is the age at which people stop being
invited to cancer screening in England. Ethical approval
was obtained from the UCL Research Ethics Committee
(registration number 5771/002), and participants
consented to participate at the start of the interview.
Those who were diagnosed with cancer were excluded
from the cancer worry questions to avoid distress.
Measures
General cancer worry was assessed with the question:
‘How often do you worry about your chance of getting
cancer yourself?’, which was scored on a 5-point scale
(never to very often). This item was adapted from the US
Health and Information National Trends Survey [24] and
has been used in many previous studies (e.g. [7, 28, 29]).
The sources of cancer worries described by those
eligible for screening in the review [23] showed great
overlap with those mentioned by cancer survivors. Thus,
we decided to assess these specific worries about cancer
using items adapted from the Concerns About Recur-
rence Scale (CARS) [20]. The CARS is a validated and
internally reliable 30-item scale to assess breast cancer
survivors’ concerns about recurrence, which we adapted
through a process of cognitive interviewing and online
piloting with asymptomatic adults in England for use in
a general population sample without a previous diagno-
sis of cancer (see Additional file 1). We included twelve
items in our survey that covered a wide range of specific
cancer worries that are also reported by those seeking
help for possible cancer symptoms [11, 21, 22] or those
eligible for cancer screening [23]. Because cancer worry
in the general population is predicated on the threat of
cancer (for example, evoked by an invitation to cancer
screening or the discovery of a symptom that may
indicate cancer), all items started with the phrase “If you
were diagnosed with cancer, would you worry that…?”
and were measured on a 4-point scale (not at all to ex-
tremely). An exploratory factor analysis showed items
loaded onto two factors: worries about the emotional
and physical consequences of a cancer diagnosis (such
as worries about the emotional upset that a cancer diag-
nosis would cause, and about chemotherapy and sur-
gery), and worries about its social consequences (such as
worries about the effect on relationships with family and
friends, interference with sense of sexuality, and financial
problems). The twelve items and factor loadings are pre-
sented in Additional file 2. Both subscales had good in-
ternal reliability (Cronbach’s α = .88 and α = .85,
respectively). We calculated mean sub-scale scores for
those with complete data on all twelve items.
Age, gender, ethnicity, marital status, and socioeco-
nomic status were assessed with simple questions. Ethni-
city was recorded using the 2011 Census question, and
recoded as ‘White’ or ‘Black, Asian, and Minority Ethnic’
(BAME; any non-White or mixed ethnic background).
Marital status was recorded as: ‘married or living as
married’, ‘single’, and ‘widowed, divorced, or separated’.
Social grade, an indicator of socioeconomic status (SES),
was recorded in four categories using the National Read-
ership Survey grades, which is based on details regarding
the occupation of a household’s chief income earner
[30]: ‘AB’ (Higher and intermediate managerial, adminis-
trative, and professional), ‘C1’ (Supervisory, clerical and
junior managerial, administrative, or professional), ‘C2’
(skilled manual workers), and ‘DE’ (semi-skilled and un-
skilled manual workers; and state pensioners, casual and
lowest grade workers, and unemployed with state bene-
fits only). ‘Don’t know’ or ‘refused’ responses were coded
as missing throughout.
Analyses
We excluded those with a cancer diagnosis or refusing to
answer this question, as well as those with missing data
on the demographic and general cancer worry variables.
We report the descriptive characteristics of the sample, in-
cluding prevalence numbers, applying weights to the data
to adjust for sampling bias in relation to age, gender,
government region, social grade, and working status.
We examined the population distribution of general
cancer worry and the two specific worries scales using
unweighted data for the univariate and multivariate lin-
ear regression models. A sensitivity analysis using
weighted data did not change the pattern or significance
of the results, so we report the unweighted results. We
also conducted subgroup analyses to examine whether
the demographic pattern of specific cancer worries dif-
fered between those who never worry about their chance
of getting cancer versus those who worry at least
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occasionally, using a dichotomised version of the general
cancer worry item. Lastly, we examined the correlations
between general cancer worry and the specific worries
subscales, and compared mean scores using multiple t-
tests with a Bonferroni correction for multiple testing.
All analyses were conducted in SPSS version 23, and an
overall alpha level of 0.05 to indicate significance.
Results
In total, 2048 respondents were interviewed; after
excluding those with a cancer diagnosis (n = 97; 4.7%),
refusing to answer this question (n = 24; 1.2%), or with
missing data on the demographic (n = 10; 0.5%) or gen-
eral cancer worry variables (n = 27; 1.3%) 1890 were left
for analysis (N = 1894 after weighting). Weighted sample
characteristics are presented in Table 1.
General cancer worry
Just over a third of respondents (37%) never worried
about getting cancer, 35% worried occasionally, 22%
sometimes, 5% often, and 2% very often. Univariate and
multivariate linear regression analyses showed that gen-
eral cancer worry was less frequent in those who were
older and from non-White ethnic backgrounds, and
more frequent in women (Table 2). There were no
differences by social grade or marital status.
Specific cancer worries
A further 117 respondents (6.2%) were excluded because
of missing data on the specific cancer worries items
(Table 1). If diagnosed with cancer, about two thirds said
they would be ‘quite a bit’ or ‘extremely’ worried about
the threat to life and emotional upset that a cancer diagno-
sis would cause (Table 3). About half would be worried
about surgery, radiation treatment, chemotherapy, and the
loss of control over life. Worries about the social implica-
tions of a cancer diagnosis were less frequently antici-
pated: slightly less than half would be worried about
financial problems or their social roles, while only about a
quarter would be worried how cancer would affect their
identity, important relationships, and sexuality. Only a
fifth would worry about how a diagnosis of cancer would
affect their gender role.
Worries about the emotional and physical consequences
The sample mean for worries about the emotional and
physical consequences of a cancer diagnosis was 2.65/4
(SD 0.80), equating to a score between ‘slightly’ and
‘quite a bit’ (Table 4). In univariate and multivariate ana-
lyses, women and those who were younger were more
likely to anticipate worrying about the emotional and
physical consequences of a cancer diagnosis, while those
from social grade DE were less likely to anticipate worry
about this compared with social grade AB, but there
were no differences by ethnicity, marital status, or social
grades C1 and C2.
Subgroup analyses showed that anticipated worry
about the emotional and physical consequences of a
cancer diagnosis was significantly higher in those who
worried at least occasionally versus those who never
worried about their chance of getting cancer (M = 2.86,
SD 0.71 vs M = 2.31, SD 0.84; t(1229) = −14.22, p < .001).
Worry about the emotional and physical consequences
was associated with younger age in both groups, and
with being female in the group who worry at least occa-
sionally about getting cancer (all p < .01; Additional file 3).
There were no associations with ethnicity, social grade,
or marital status for either group.
Worries about the social consequences
The sample mean for worries about the social conse-
quences of a cancer diagnosis was 2.04/4 (SD 0.75), equat-
ing to feeling slightly worried (Table 5). Univariate and
multivariate analyses showed that women, those who were
younger, and those from BAME groups anticipated greater
worry about the social consequences. Those who were sin-
gle would be more worried about the social consequences
of a cancer diagnosis than those who were married in un-
adjusted analyses, but this relationship was attenuated by
adjusting for other demographic differences. There was no
association with social grade.
Subgroup analyses showed that anticipated worry about
the social consequences of a cancer diagnosis was signifi-
cantly higher in those who worried at least occasionally
compared with those who never worried about their
chance of getting cancer (M = 2.20, SD 0.73 vs M = 1.78,
SD 0.71; t(1771) = −11.81, p < .001). In both groups, being
worried about the social consequences of a cancer diagno-
sis was associated with younger age (Additional file 3). For
those who worried at least occasionally about getting
cancer, worry about the social consequences was also
associated with being female and being from an ethnic mi-
nority background. As per the main analyses, there were
no associations with social grade or marital status.
The relationships between general cancer worry and the
specific cancer worries
Anticipated worry about the emotional and physical con-
sequences of a cancer diagnosis (M = 2.65/4, SD = 0.80)
was significantly higher than worry about the social conse-
quences of a cancer diagnosis (M = 2.04/4, SD = 0.75;
t(1772) = 41.2, p < .001), or general cancer worry (M=
2.00/5, SD = 0.98; t(1772) = 26.6, p < .001). There was no
difference between the latter two (t(1772) = 1.81, p = .07).
The correlations between general cancer worry and the
two specific cancer worries sub-scales were moderate: r
= .349 (p < .001; emotional and physical consequences)
and r = .305 (p < .001; social consequences). However, the
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two sub-scales of specific cancer worries were strongly
correlated (Pearson’s r = .683, p < .001).
Discussion
This is the first study to examine the prevalence and
demographic distribution of specific worries about can-
cer in the general population, and to compare this with
general cancer worry. Nearly two thirds of the English
adult population without a cancer diagnosis worry at
least occasionally about getting cancer, and a fifth to two
thirds anticipated worrying about specific aspects of the
cancer experience if they were diagnosed. The popula-
tion distributions for these worries partly overlap, but
there may be important implications for future research
where they diverge, as described below.
The prevalence and population distribution of general
cancer worry in our study was similar to other
population-based studies in the UK and US [25, 27, 31],
with higher general cancer worry in women and those
who are younger [25–27, 32]. The gender difference in
cancer worry may be partly explained by women being
more anxious in general [33], although previous studies
found only moderate correlations between cancer worry
and general anxiety [16, 27]. Little is known about the
negative association of cancer worry with age. Possible
explanations include greater familiarity with cancer and
cancer outcomes in others (including positive ones), or
less fear of cancer outcomes such as disability and death
due to advanced age. Some studies have shown that
older adults are indeed less fearful of death [34], and
40% of older adults in England believe that cancer is a
good way to die [35]. Unlike previous studies [16, 27],
we found that general cancer worry was lower among
those from BAME backgrounds. However, levels of
Table 1 Characteristics of the weighted samples
General cancer worry (N = 1894) Specific cancer worries (N = 1782)
Characteristic N (%)a N (%)a
Age
Mean, SD 42.8 (15.3) 42.9 (15.3)
Range 18–70 18–70
Gender
Male 936 (49.4) 884 (49.6)
Female 957 (50.6) 898 (50.4)
Ethnicity
White 1596 (84.3) 1513 (84.9)
BAMEb 298 (15.7) 269 (15.1)
Social grade
AB (highest) 505 (26.7) 486 (27.3)
C1 528 (27.9) 499 (28.0)
C2 425 (22.4) 392 (22.0)
DE (lowest) 436 (23.0) 405 (22.7)
Marital status
Married or living as married 1194 (63.1) 1122 (63.0)
Single 522 (27.5) 490 (27.5)
Widowed, separated, or divorced 178 (9.4) 170 (9.5)
General cancer worry (frequency)
Never 701 (37.0) 658 (36.9)
Occasionally 657 (34.7) 618 (34.7)
Sometimes 415 (21.9) 390 (21.9)
Often 85 (4.5) 82 (4.6)
Very often 36 (1.9) 34 (1.9)
Specific cancer worries (12 items)
Complete data 1782 (94.1) 1782 (100.0)
Missing data 112 (5.9) –
aUnless otherwise stated
bBAME Black, Asian, and Minority Ethnic
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worry vary between ethnic groups [26, 32, 36], and may
thus depend on the representation of specific ethnic
groups in the sample. We could not explore this further
due to small numbers in the ethnic groups.
In terms of the specific cancer worries, more people
would be worried about the emotional and physical
consequences of a cancer diagnosis than about the social
consequences, although the latter were still reported by
a fifth to half the population. This is the first study to
examine specific cancer worries in the general popula-
tion, although a study in breast cancer survivors and a
qualitative review of cancer worries in cancer screening
Table 2 Mean scores and demographic correlates of general cancer worry (range: 1–5; unweighted data; N = 1890)
Characteristic General cancer worry Univariate$ Multivariate$,a
M (SD) B (SE) β Significance B (SE) β Significance
Total sample 1.99 (0.98)
Age −.003 (.001) −.053 p < .05 −.004 (.002) −.071 p < .01
Gender
Male 1.87 (0.94) Ref Ref
Female 2.10 (1.02) .226 (.045) .115 p < .001 .214 (.046) .108 p < .001
Ethnicity
White 2.02 (0.98) Ref Ref
BAMEb 1.88 (1.00) −.141 (.062) −.052 p < .05 −.164 (.063) −.061 p < .01
Social grade
AB (highest) 2.00 (0.90) Ref Ref
C1 1.97 (0.95) −.039 (.050) −.081 p = .43 −.039 (.069) −.018 p = .58
C2 2.00 (0.97) .001 (.055) .0003 p = .99 −.007 (.073) −.003 p = .92
DE (lowest) 2.02 (1.07) .032 (.048) .015 p = .51 .027 (.069) .013 p = .69
Marital status
Married or living as married 2.01 (0.97) Ref Ref
Single 1.97 (1.00) −.034 (.050) −.016 p = .50 −.074 (.055) −.034 p = .18
Widowed/separated/divorced 1.96 (1.04) −.044 (.073) −.014 p = .55 −.049 (.078) −.016 p = .53
R2 = .021
$Values in bold are significant at p < .05
aMutually adjusted for age, gender, ethnicity, social grade, and marital status
bBAME = Black, Asian, and Minority Ethnic
Table 3 Response rates and distributions for the specific cancer worry items (weighted; N = 1894)










Worries about the emotional and physical consequences
1.you would require surgery? 1796 (94.8) 349 (19.4) 513 (28.6) 592 (33.0) 342 (19.0)
2.it would upset you emotionally? 1799 (95.0) 190 (10.6) 443 (24.6) 616 (34.2) 550 (30.5)
3.you would require chemotherapy? 1796 (94.8) 292 (16.3) 455 (25.3) 659 (36.7) 390 (21.7)
4.you would require radiation treatment? 1799 (95.0) 337 (18.7) 497 (27.6) 636 (35.4) 329 (18.3)
5.it would make you feel that you don’t have control over your life? 1794 (94.7) 335 (18.7) 551 (30.7) 540 (30.1) 368 (20.5)
6.it would threaten your life? 1799 (95.0) 211 (11.7) 373 (20.7) 638 (35.5) 577 (32.1)
Worries about the social consequences
7.it would make you feel less of a (wo)man? 1799 (95.0) 1044 (58.1) 416 (23.1) 230 (12.8) 109 (6.1)
8.it would interfere with your sense of sexuality? 1800 (95.0) 868 (48.2) 467 (25.9) 326 (18.1) 139 (7.7)
9.it would threaten your identity? 1795 (94.8) 781 (43.5) 507 (28.2) 359 (20.0) 148 (8.2)
10.it would hurt your relationships with friends and family? 1800 (95.0) 814 (45.2) 482 (26.8) 329 (18.3) 175 (9.7)
11.it would cause financial problems for you? 1797 (94.9) 425 (23.6) 510 (28.4) 531 (29.5) 331 (18.4)
12.it would keep you from fulfilling important roles? 1797 (94.9) 361 (20.1) 548 (30.5) 566 (31.5) 322 (17.9)
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Table 4 Mean scores and demographic correlates of worries about the emotional and physical consequences of a cancer diagnosis
(range: 1–4; unweighted; N = 1773)
Characteristic Emotional and physical worries Univariate$ Multivariate$,a
M (SD) B (SE) β Significance B (SE) β Significance
Total sample 2.65 (0.80)
Age −.007 (.001) −.143 p < .001 −.007 (.001) −.148 p < .001
Gender
Male 2.51 (0.76) Ref Ref
Female 2.77 (0.82) .256 (.038) .159 p < .001 .246 (.038) .153 p < .001
Ethnicity
White 2.65 (0.79) Ref Ref
BAMEb 2.62 (0.86) −.030 (.053) −.013 p = .57 −.076 (.053) −.034 p = .15
Social grade
AB (highest) 2.70 (0.77) Ref Ref
C1 2.69 (0.78) .052 (.042) .029 p = .22 −.050 (.057) −.028 p = .38
C2 2.68 (0.80) .034 (.046) .017 p = .47 −.042 (.060) −.022 p = .48
DE (lowest) 2.57 (0.84) −.113 (.041) −.066 p < .01 −.155 (.057) −.090 p < .01
Marital status
Married or living as married 2.64 (0.79) Ref Ref
Single 2.69 (0.84) .049 (.042) .028 p = .24 .005 (.046) .003 p = .91
Widowed/separated/divorced 2.60 (0.80) −.052 (.061) −.020 p = .40 .057 (.065) .022 p = .37
R2 = .050
$Values in bold are significant at p < .05
aMutually adjusted for age, gender, ethnicity, social grade, and marital status
bBAME = Black, Asian, and Minority Ethnic
Table 5 Mean scores and demographic correlates of worries about the social consequences of a cancer diagnosis (range: 1–4;
unweighted; N = 1773)
Characteristic Social worries Univariate$ Multivariate$,a
M (SD) B (SE) β Significance B (SE) β Significance
Total sample 2.04 (0.75)
Age −.011 (.001) −.239 p < .001 −.011 (.001) −.226 p < .001
Gender
Male 1.95 (0.72) Ref Ref
Female 2.12 (0.77) .171 (.035) .114 p < .001 .160 (.035) .107 p < .001
Ethnicity
White 2.01 (0.73) Ref Ref
BAMEb 2.24 (0.83) .226 (.049) .108 p < .001 .153 (.049) .073 p < .01
Social grade
AB (highest) 1.99 (0.72) Ref Ref
C1 2.05 (0.74) .009 (.039) .006 p = .82 −.010 (.052) −.006 p = .84
C2 2.11 (0.74) .083 (.043) .046 p = .05 .086 (.055) .047 p = .12
DE (lowest) 2.02 (0.78) −.034 (.038) −.021 p = .38 −.012 (.052) −.008 p = .82
Marital status
Married or living as married 2.02 (0.73) Ref Ref
Single 2.13 (0.78) .128 (.039) .078 p < .01 .006 (.042) .003 p = .90
Widowed/separated/divorced 1.95 (0.75) −.109 (.057) −.045 p = .06 .047 (.059) .019 p = .43
R2 = .076
$Values in bold are significant at p < .05
aMutually adjusted for age, gender, ethnicity, social grade, and marital status
bBAME = Black, Asian, and Minority Ethnic
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also found higher anticipation of treatment and death
worries than worries about cancer’s social implications
[20, 23]. Many people believe that ‘a diagnosis of cancer
is a death sentence’ and that ‘cancer treatment is worse
than the cancer itself ’, which may explain this finding
[37, 38]. We also noted the high prevalence of worry
about financial consequences (76% would worry at least
slightly), despite healthcare in England being provided
free at the point of delivery via the National Health Ser-
vice. Cancer patients often incur many indirect costs,
however, such as for transportation, childcare, and lost
wages [39], and the high prevalence of anticipated finan-
cial worry may reflect this.
This study has the following implications for future re-
search. First, the population distribution of the specific
worries about cancer was similar to that of general cancer
worry, except for ethnicity. While we found no ethnic dif-
ferences in worries about emotional and physical conse-
quences, those from BAME backgrounds worried more
about the social consequences of a cancer diagnosis. This
could reflect cancer being taboo or stigmatised in some
ethnic minority populations [40–42], and may help
explain their lower uptake of cancer screening [43–45],
and tendency to delay help-seeking for symptoms [46].
Future research into the behavioural effects of cancer
worry in ethnic minority populations may benefit from
distinguishing general cancer worry from specific worries
about the social consequences of a cancer diagnosis.
Secondly, previous studies suggest that general cancer
worry sometimes motivates help-seeking and attendance
at cancer screening [10], but specific cancer worries may
act as a deterrent [11, 23]. Although we did not assess
the behavioural associations of the cancer worries in-
cluded in this study, we did show that general cancer
worry and specific cancer worries are only moderately
correlated, and it may be important to distinguish them
when assessing their behavioural effects. For example,
behavioural theories such as the EPPM [14] would
predict that the behavioural responses for general cancer
worry and specific worries may be different: general
cancer worry may motivate cancer screening attendance
to obtain reassurance to deal with the threat of cancer,
while fears about cancer treatment may motivate avoid-
ance of screening to avoid a diagnosis, thereby dealing
with the threat of cancer treatment. Given that 50% of
older adults in the UK believe that most cancer
treatment is worse than the cancer itself [38], distin-
guishing between the specific origins of cancer worry
may help determine when cancer worry acts as a motiv-
ator and when it acts as a deterrent to cancer preventive
behaviours. Assessing the behavioural effects of specific
cancer worries was outside the scope of this study,
however, and further research into these behavioural
effects is needed.
Our study had some limitations. The specific worry
items used were from a scale that had been previ-
ously developed and validated with breast cancer pa-
tients [20]. Although we used cognitive interviewing
and an online pilot study to ensure items were clear
and relevant to people without a cancer diagnosis,
more work is needed to fully validate the scale for
use in the general population. This study is only a
first step in the exploration of specific cancer worries
in the general population, and future research into
specific cancer worries and their behavioural effects
would benefit from further validation of this scale.
Furthermore, a substantial proportion of respondents
(7%) had missing data on the specific cancer worry
items, which could have influenced estimates of their
prevalence and population distribution. However, if
those who worry are more likely to avoid answering
these questions, then our prevalence estimates may
be an underestimate. The cross-sectional nature of
this study prevents any conclusions about temporal or
causal relationships (such as whether cancer worry
decreases with age), and longitudinal studies would be
needed to examine how cancer worries evolve over
time. Cancer worries may be affected by family his-
tory of cancer, but we were unable to measure this in
the current study and future studies may want to
explore this relationship. Finally, we aimed to exam-
ine whether there were differences in the prevalence
and sociodemographic distribution of twelve specific
worries about cancer. We did not specify a specific
type of cancer, although the importance of these wor-
ries may vary by cancer type, for example, depending
on the treatment options and survivability of a
particular cancer type. Although this was outside of
the scope of the current study, future studies could
explore whether the prevalence of specific cancer
worries varies by cancer type.
Conclusion
In conclusion, many aspects of cancer may evoke
worry in the general population, including general
worry about getting cancer and anticipated worries
about the emotional, physical, and social conse-
quences of a cancer diagnosis. This study can serve
as a starting point to examine the behavioural effects
of different cancer worries, and may ultimately help
allay undue worries in those who are deterred by
them.
Endnotes
1In population research, the terms ‘cancer fear’ and
‘cancer worry’ are often used interchangeably. In clinical
psychology, ‘fear’ refers to the emotional response to an
immediate and observable threat and ‘worry’ refers to a
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more cognitive process where the threat is often antici-
patory in nature [Rachman, S. Anxiety, 2nd ed. Hove:
Psychology Press; 2004]. Consistent with these defini-
tions, we will use the term ‘cancer worry’ to describe the
negative emotional reaction to the threat of cancer in an
asymptomatic population, except when referring to
previous studies, where we will use the term that is used
by the authors.
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